See more : Shenzhen Sea Star Technology Co., Ltd. (002137.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Nitta Gelatin Inc. (4977.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nitta Gelatin Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- IKK Holdings Inc . (2198.T) Income Statement Analysis – Financial Results
- Alumis Inc. Common Stock (ALMS) Income Statement Analysis – Financial Results
- Como Co.,Ltd. (2224.T) Income Statement Analysis – Financial Results
- Northern Minerals Limited (NTU.AX) Income Statement Analysis – Financial Results
- TISCO Financial Group Public Company Limited (TISCO-R.BK) Income Statement Analysis – Financial Results
Nitta Gelatin Inc. (4977.T)
About Nitta Gelatin Inc.
Nitta Gelatin Inc. engages in the production and sale of edible gelatin, pharmaceutical gelatin, and photographic gelatin in Japan. The company manufactures and sells related products made from collagen for animal bones and skin, and fish scales and skin; and gelatin for applications in industrial sectors comprising food and pharmaceutical markets; collagen peptide, which is recognized as a bioactive compound and a material that has bioregulatory functions, produced using its proteolytic technology. It also manufactures other food materials; and stabilizers for confectionery, desserts, delicatessen items, chilled foods, etc. In addition, the company manufactures and sells collagen and medical gelatin for medical device manufacturers, research institutions, and others that are used as a biomaterial for artificial skin and bone. Nitta Gelatin Inc. was founded in 1918 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.42B | 39.19B | 31.78B | 30.55B | 34.54B | 36.46B | 37.78B | 36.58B | 36.89B | 31.91B | 32.81B | 28.77B | 27.76B | 27.92B |
| Cost of Revenue | 31.70B | 30.29B | 24.78B | 24.25B | 27.24B | 29.08B | 29.81B | 28.16B | 29.20B | 25.94B | 26.33B | 22.08B | 20.92B | 21.60B |
| Gross Profit | 8.72B | 8.90B | 7.00B | 6.30B | 7.30B | 7.39B | 7.96B | 8.42B | 7.69B | 5.97B | 6.48B | 6.69B | 6.84B | 6.33B |
| Gross Profit Ratio | 21.58% | 22.71% | 22.04% | 20.63% | 21.13% | 20.25% | 21.08% | 23.01% | 20.85% | 18.71% | 19.76% | 23.26% | 24.63% | 22.65% |
| Research & Development | 1.33B | 1.08B | 934.00M | 819.00M | 965.00M | 1.07B | 1.11B | 1.06B | 1.06B | 915.00M | 1.00B | 1.03B | 0.00 | 0.00 |
| General & Administrative | 4.68B | 4.64B | 3.78B | 3.54B | 3.93B | 4.72B | 5.02B | 4.98B | 5.50B | 3.92B | 3.81B | 3.46B | 0.00 | 0.00 |
| Selling & Marketing | 866.00M | 1.21B | 975.00M | 787.00M | 821.00M | 840.00M | 910.00M | 940.00M | 956.00M | 805.00M | 822.00M | 740.00M | 0.00 | 0.00 |
| SG&A | 5.55B | 5.85B | 4.76B | 4.32B | 4.75B | 5.56B | 5.93B | 5.92B | 6.46B | 4.73B | 4.63B | 4.20B | 0.00 | 0.00 |
| Other Expenses | 0.00 | 20.00M | 126.00M | 102.00M | 99.00M | 129.00M | 62.00M | 67.00M | 115.00M | 34.49M | 25.32M | 87.00M | 31.69M | 35.98M |
| Operating Expenses | 6.88B | 6.64B | 5.44B | 4.95B | 5.61B | 6.49B | 6.87B | 6.80B | 6.42B | 5.58B | 5.53B | 5.07B | 4.82B | 4.84B |
| Cost & Expenses | 38.58B | 36.93B | 30.22B | 29.19B | 32.85B | 35.57B | 36.68B | 34.96B | 35.61B | 31.52B | 31.86B | 27.15B | 25.75B | 26.44B |
| Interest Income | 48.00M | 7.00M | 2.00M | 5.00M | 6.00M | 10.00M | 15.00M | 17.00M | 27.00M | 812.00K | 4.79M | 786.00K | 684.00K | 1.06M |
| Interest Expense | 190.00M | 171.00M | 97.00M | 107.00M | 187.00M | 236.00M | 235.00M | 234.00M | 315.00M | 151.58M | 133.87M | 147.30M | 167.70M | 180.57M |
| Depreciation & Amortization | 1.73B | 1.63B | 1.42B | 1.39B | 1.49B | 1.62B | 1.72B | 1.51B | 1.56B | 1.12B | 914.01M | 825.23M | 841.77M | 898.49M |
| EBITDA | 3.56B | 3.89B | 2.98B | 2.75B | 737.00M | 2.51B | 2.82B | 3.13B | 2.84B | 2.20B | 2.12B | 2.91B | 2.97B | 2.57B |
| EBITDA Ratio | 8.81% | 10.18% | 10.22% | 9.37% | 10.07% | 8.49% | 7.85% | 9.78% | 7.74% | 7.00% | 6.59% | 10.34% | 10.85% | 8.82% |
| Operating Income | 1.84B | 2.26B | 1.56B | 1.36B | 1.69B | 898.00M | 1.10B | 1.62B | 1.27B | 392.66M | 955.57M | 1.62B | 2.02B | 1.49B |
| Operating Income Ratio | 4.54% | 5.76% | 4.91% | 4.44% | 4.89% | 2.46% | 2.90% | 4.42% | 3.45% | 1.23% | 2.91% | 5.63% | 7.26% | 5.32% |
| Total Other Income/Expenses | -1.89B | 542.00M | 103.00M | -50.00M | -2.63B | 133.00M | -1.08B | -190.00M | -233.00M | 542.00M | 114.49M | 319.63M | -51.22M | 8.03M |
| Income Before Tax | -50.00M | 2.80B | 1.66B | 1.31B | -943.00M | 1.03B | 43.00M | 1.43B | 1.04B | 933.22M | 1.07B | 1.94B | 1.96B | 1.49B |
| Income Before Tax Ratio | -0.12% | 7.15% | 5.23% | 4.27% | -2.73% | 2.83% | 0.11% | 3.90% | 2.82% | 2.92% | 3.26% | 6.74% | 7.08% | 5.35% |
| Income Tax Expense | 1.11B | 542.00M | 630.00M | 373.00M | -420.00M | 214.00M | 499.00M | 660.00M | 428.00M | 353.06M | 418.40M | 385.96M | 581.21M | 436.38M |
| Net Income | -1.85B | 1.56B | 726.00M | 742.00M | -694.00M | 989.00M | -615.00M | 693.00M | 477.00M | 610.07M | 665.49M | 1.57B | 1.38B | 1.05B |
| Net Income Ratio | -4.58% | 3.98% | 2.28% | 2.43% | -2.01% | 2.71% | -1.63% | 1.89% | 1.29% | 1.91% | 2.03% | 5.44% | 4.96% | 3.77% |
| EPS | -101.93 | 85.97 | 40.12 | 40.98 | -37.77 | 53.83 | -33.47 | 37.74 | 26.00 | 33.20 | 37.90 | 96.72 | 99.87 | 80.19 |
| EPS Diluted | -101.93 | 85.97 | 40.12 | 40.98 | -37.77 | 53.83 | -33.47 | 37.74 | 26.00 | 33.20 | 37.90 | 96.72 | 99.87 | 80.19 |
| Weighted Avg Shares Out | 18.15M | 18.12M | 18.10M | 18.11M | 18.37M | 18.37M | 18.37M | 18.37M | 18.37M | 18.37M | 17.56M | 15.77M | 13.50M | 12.52M |
| Weighted Avg Shares Out (Dil) | 18.15M | 18.12M | 18.10M | 18.11M | 18.37M | 18.37M | 18.37M | 18.37M | 18.37M | 18.37M | 17.56M | 15.77M | 13.50M | 12.52M |
Source: https://incomestatements.info
Category: Stock Reports